Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Hepatocellular Carcinoma With Triphasic Helical CT vs. US With Alpha-fetoprotein in Patients With Advanced Liver Disease

NCT01350167 is registered in ClinicalTrials.gov with Minneapolis Veterans Affairs Medical Center as lead sponsor.

NCT NCT01350167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01350167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Hepatocellular Carcinoma With Triphasic Helical CT vs. US With Alpha-fetoprotein in Patients With Advanced Liver Disease
Lead sponsor
Minneapolis Veterans Affairs Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2001
Completion date
December 31, 2021
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, end stage liver disease, hepatitis c